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Abstract
The accuracy of disease metrics is dependent on the quality of population-based data.
Many diseases, including diabetes, are age and sex dependant. Accurate age- and sexspecific population survey data, population estimates and projections are required to
assess the scale and trends in the burden of these diseases.
No assessment of the quality of population data being used in the UAE diabetes metrics
has been published. We provide insight into the availability and quality of published
population data, which is currently being used to inform diabetes research and health
services planning in the UAE.
We show the absence of credible population-based data impedes the accurate
assessment of disease prevalence, incidence and trends. This means that many
statements about the burden of this disease in relative and absolute terms are not
robust.

There has been only one study of sufficient reliability of the prevalence of diabetes
in the UAE and this was undertaken in 2000. Hence the calculation and reporting of
trends is problematic. Population estimates for the UAE are based on out of date data
and are extremely variable. Population projections for the UAE and other Middle East
countries with large expatriate labour forces are improbable.
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The clinical and other implications of accurate population-based metrics are wide
reaching. If prevalence rates are to be used to guide public policy and infrastructure
planning, then we need to use valid data, including population and population-based
data.
Whilst specific reference is made to diabetes, and the issues affecting the United Arab
Emirates and the Gulf Cooperation Council Countries of the Middle East; the impact
of inaccurate population–based metrics have application in other regions, and other
diseases.
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Introduction

In the United Arab Emirates (UAE), a grim picture is painted
regarding the prevalence of diabetes and its impact on society.
This picture is informed by global [1-3] and regional research
[4]. Annual metrics show “alarmingly high” [1,5] diabetes and
impaired glucose tolerance (IGT) prevalence in UAE, and other
Gulf Cooperation Council (GCC) countries. The International
Diabetes Federation (IDF) estimated 745,940 people in the
UAE have diabetes in 2013, with the comparative prevalence of
diabetes in the adult population (20-79 years) being 18.98%. By
Submit Manuscript | http://medcraveonline.com

comparison, the global comparative prevalence in 2013 is 8.26%
[1].

The alarming language contained in the IDF Diabetes
Atlas [1] is frequently restated in regional newspapers, where
improvements in the world ranked position for diabetes
prevalence are also presented as achievements [6]. Consequently
in the UAE and GCC, awareness that diabetes is a problem is high.
IDF projections are that by 2035, in the Middle East and North
African region (MENA), the number of people with diabetes
(diagnosed and undiagnosed) will increase by 96.2% [1]. The
picture reported is of an ageing population, with struggling health
systems [7], both important drivers for public health expenditure
in the UAE [8].
The reliability of disease metrics is dependent on valid
datasets being available [9]. The reliability of IDF diabetes
estimates for the UAE depends on the reliability of the underlying
survey data [4] and population estimates [10,11]. In generating
the prevalence of diabetes and other metrics, the IDF uses the
J Diabetes Metab Disord Control 2014, 1(4): 00024
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United Nation’s (UN) adult population estimates (ages 20-79)
as the data denominator, and undertakes age standardization of
diabetes rates using the World Standard Population provided by
the World Health Organization (WHO) [12,13]. Many diseases,
including diabetes, are age and sex dependent. Accurate age- and
sex-specific population survey data, population estimates and
projections are required to assess the scale and trends in the
burden of these diseases [1,12,14].
No assessment of the quality of publicly available population
data being used in the UAE diabetes metrics has been published.

Examining the reliability of diabetes metrics for the UAE
has offered more generic insights and lessons. This paper
demonstrates the uncertainty that exists in population data and
IDF calculations for the UAE. We show the absence of credible
population-based data impedes the accurate assessment of
disease prevalence, incidence and trends. This means that many
statements about the burden of diabetes in relative and absolute
terms are not robust.

Diabetes Metrics

The key metrics of the scale of diabetes are listed in Figure
1. All these rates are directly dependent on population-based
estimates. The accuracy of total population estimates and the
quality of population data could significantly affect the reliability
of these metrics.

Quality of Population Data and Estimates for UAE
Population estimates

There is significant uncertainty in total population estimates
for the UAE. UN world population estimates and projections
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[15] rely heavily upon official country data, last available for
UAE in 2010 [10]. The UN produces estimates structured in
5-year age intervals, which can be compared against the WHO’s
World Standard Population [13] for international comparison of
populations. The UAE has not published population estimates by
5-year age groups since the last national census undertaken in
2005 [10].
Official UAE population estimates are based on the latest
national census undertaken in 2005; birth and death data
available from the Ministry of Health (MOH), Health Authority
Abu Dhabi (HAAD) and Dubai Health Authority (DHA); and net
migration data available from Ministry of Interior.

Other population estimates may show considerable variance
from those produced by the UAE National Bureau of Statistics
(NBS) and by UN. The range of population estimates are listed in
(Figure 2) [16-28], and graphed in (Figure 3). The WHO, World
Bank and IDF all use UN population estimates and projections in
their metrics. As shown in (Figure 3), for 2010, the highest value
is 79% greater than the lowest value.
Unofficial or other population statistics influence health
policy and practice in UAE. To generate health metrics for Abu
Dhabi, HAAD uses its own population estimates [29], which are
higher than those produced by the NBS or the Statistics Centre
Abu Dhabi (SCAD).
Researchers with HAAD’s Weqaya programme, which
achieved almost complete cardiovascular risk factor screening
of the citizen population in the emirate of Abu Dhabi indicate
“there may have been inaccuracies in the population figures used
as denominators here, which were derived from a 2005 census”
[30]. Blair & Sharif [31] call the 2009 population estimation

Age speci�ic prevalence rates are estimated using survey data from well structured probability sampling, by dividing the number of
people with diabetes found in each age group in the sample by the total number sampled in that age group.

Age/sex speci�ic prevalence rates are estimated using survey data from well structured probability sampling, by dividing the number
of people with diabetes found in each age/sex group in the sample by the total number sampled in that age/sex group.

Estimated total number of persons with diabetes in a population is calculated by multiplying the age (or age/sex) speci�ic rates by the
number of people of that age (or age/sex) group in the population.

The crude prevalence rate is the above estimate of the total numbers in the population divided by the total population. This is called the
"country prevalence rate" in IDF data.
An age standardized prevalence rate for a country is calculated by applying that country's age speci�ic prevalence rates to a standard
population, usually a "world" population, to remove the effect of different age structure in countries. This is the "comparative
prevalence" rate used by IDF in global comparisons of diabetes prevalence.
Age /sex standardized prevalence rate for a country is calculated by applying that country's age/sex speci�ic prevalence rates to a
standard population, usually a "world" population, to remove the effect of different age/sex structure in countries.

Incidence is the count of people in a population who have been diagnosed as having diabetes in a given time period - the number of new
cases.
The crude incidence rate is the incidence number divided by the total population. It is not used for comparison with other populations.
The crude death rate is the number of deaths divided by the population, usually presented per 1,000 populations.
The age/sex speci�ic mortality rate is the deaths per 1,000 populations of age/sex groups.

Diabetes related mortality rates are deaths per 1,000 where cause of death is diabetes. Usually relates to primary cause of death.

Figure 1: Key metrics of diabetes.
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Total Population Estimate
5,473,972
5,524,000
9,346,000
9,206,000
8,100,000
8,925,000
7,891,000
8,925,000
8,442,000
8,264,000
7,512,000
5,400,000
5,055,000
4,707,000
7,718,319
4,106,427
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Source
CIA Factbook [ 16]
International Monetary Fund [ 1 7 ]
United Nations [ 1 8 ]
World Bank [ 1 9 ]
World Health Organization [ 2 0 ]
World Bank [ 1 9 ]
Population Reference Bureau [ 2 1 ]
World Bank [ 1 9 ]
World Health Organization [ 2 2 ]
World Health Organization [ 2 3 ]
Britannica [ 2 4 ]
World Bank [ 1 9 ]
United Nations [ 1 8 ]
World Health Organization [ 2 2 ]
World Bank [ 1 9 ]
National Bureau Statistics, UAE [ 1 0 ]
WHO, EMRO [ 2 5 ]
United Nations [ 1 1 ]
World Health Organization [ 2 6 ]
World Bank [ 1 9 ]
Population Reference Bureau [ 2 3 ]
International Monetary Fund [ 2 4 ]
World Bank [ 2 7 ]
World Bank [ 1 9 ]
National Bureau Statistics, UAE (Census) [ 2 8 ]

Figure 2: Common estimates of total population: UAE.

Figure 3: Range of population estimates for UAE, 2005-2013.

Reference Year
2013
2013
2013
2013
2012
2012
2012
2011
2011
2011
2011
2011
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2010
2009
2005

3/9

Date Published
July 2013
2013
2014
2012
2014
2013
2012
2012
March 2011
2011
2012
2010
2010
1 July 2011
2014
2005

“improbable” and point out that high population growth means
that population counts enumerated in formal censuses quickly
become inaccurate. UAE newspapers [32,33] also report a lack
of confidence in NBS population estimates for planning purposes.
The National newspaper reports in 2011 “the lack of a census in
2010 means more exact figures are unavailable” [33].

with diabetes and the “burden of disease” increase, even if the
prevalence remains the same. Exponential growth, significantly
greater than other GCC countries and world growth, has been
the most dramatic feature of the UAE population [35]. Projected
population growth is expected to be similar to other GCC
countries and greater than world rates as shown in Figure 4 [36].

As a population grows, both the absolute number of people

Like all GCC countries, demographic reporting in the UAE is

Population growth

Population constituency and gender

Citation: Hunter LH, Robb WF, Brownie SM (2014) The “Secret” Impact of Population Statistics on the Metrics of Diabetes. J Diabetes Metab Disord
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usually limited to “citizens” and “non-citizens”. The nationalities
of the 88.5% of the UAE population who are expatriates are
not publically available. Yet these sub-populations have very
different demographic characteristics, particularly age structure,
gender balance and growth, and different diabetes prevalence [4].
These unusual population features impact upon the prevalence,
incidence and mortality of diabetes in the UAE.
UAE has a known population and gender imbalance,
generated by large numbers of young, single, mainly male
expatriate workers [34]. Between 1995 and 2005, the noncitizen population structure in the UAE saw large increases in
percentages in males aged 20 to 34; small decreases in males
35 to 49; small increases in males aged 50 to 64 years; small
increases in females in most age groups from 20 to 64 years; and
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large decreases in percentages in age groups less than 20 years
(Figure 5) [10]. The non-citizen profile clearly demonstrates
UAE’s increased dependence on temporary migrant workers. By
2010, citizens comprised just 11.5% of the total population of
UAE [10].

Population ageing

Like other countries in the GCC, UAE is a young population.
According to UN World Population Prospects 2012 [36], by
2050, the UAE population will age substantially. By 2050, the UN
estimates that the percentage of the population under 15 years
will drop (from 20.0% to 11.2%). The 60-79 years group will
grow (from 0.6% to 32.8%). The bulk of the population (54.7%)
will be aged 15-59 and just 1.2% will be over 80 years. If correct,

Figure 4: Population change, other GCC and World, 1950 to 2030.
Data source: UN, Population Division, World Population Prospects: The 2012 Revision, accessed at http://esa.un.org/unpd/wpp/unpp/panel_
population.htm in April 2014

Figure 5: Population structure changes for non-citizens UAE 1995 to 2005.
Data source: UAE National Bureau of Statistics, Census data, http://www.uaestatistics.gov.ae/ReportsByDepartmentEnglish/tabid/104/Default.
aspx?MenuId=1
Citation: Hunter LH, Robb WF, Brownie SM (2014) The “Secret” Impact of Population Statistics on the Metrics of Diabetes. J Diabetes Metab Disord
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the prevalence of diabetes, and the burden on the UAE health
system would increase significantly (Figure 6) [36].
However, as we will show, the UN wrongly ages the transient
non-citizen population, skewing the population profile towards
increased numbers of elderly men and women. In fact, only the
profile of the small citizen sub-population is aging.

An official NBS population profile for UAE is not available.
Instead, Abu Dhabi Emirate’s 2012 population estimates (Figure
7) will demonstrate the difference between citizen and noncitizen population structure, and illustrate the reason why the
2012 UN World Population Prospects are improbable.

The Abu Dhabi citizen sub-population shown at the core of
the population profile demonstrates a traditional population
pyramid of a young population having more than replacement
size families. As this population ages, the crude prevalence of
diabetes will increase for citizens.
The non-citizen sub-population consists of a large, young
largely male, adult migrant population come to work, but not to
settle, they stay several years, and return home before 65 years
of age [9]. This is clear in the population profile.

Whilst the citizen population profile of the Abu Dhabi ages;
the non-citizen population profile does not. The non-citizen
population is constantly replaced by new workers of the same
age range. While the factors creating the population imbalance
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remain the same, the status quo population and gender imbalance
will be preserved.

In Figure 8, it can be seen that between 2005 and 2012, the
main growth in non-citizen population for Abu Dhabi Emirate
is for males at ages between 20 and 34 years, and that the
percentage of the population in almost all age groups over 35
years has decreased for both males and females. Population
shares below the age of 20 years have reduced. In Abu Dhabi, as
in UAE as a whole, the non-citizen replacement sub-population
cohort does not age. There are very few non-citizens aged 65 and
over. Therefore, increases in diabetes incidence due to ageing are
limited to that from citizens.

Quality of Diabetes Metrics
Diabetes prevalence

In the UAE, just one study has continuously informed the IDF
estimation of diabetes prevalence [37]. This population-based
survey undertaken by Malik et al. [4] in 1999-2000, excluded all
expatriate workers living in labour camps. These workers are
included in UAE census counts and population estimates. They
represent a very large segment of the young adult population
aged 20 to 39 years.
Their exclusion from Malik’s study has the potential to bias
prevalence estimates to the extent that rates for these people
differ from others in the population. For example, the Malik

Figure 6: Projected population structure, UAE 2050.
Data Source: United Nations, Department of Economic and Social Affairs, Population Division (2013). World Population Prospects: The 2012
Revision, DVD Edition
Citation: Hunter LH, Robb WF, Brownie SM (2014) The “Secret” Impact of Population Statistics on the Metrics of Diabetes. J Diabetes Metab Disord
Control 1(4): 00024. DOI: 10.15406/jdmdc.2014.01.00024
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Figure 7: Population structure, Abu Dhabi Emirate, mid-2012.
Source: SCAD (2013), Statistical Year Book, accessed April 2014 at http://www.scad.ae/en/statistics/Pages/Statistics.aspx?ThemeID=4&TopicI
D=27&SubTopicID=53&PublicationID=410

Figure 8: Non-citizen Population structure, Abu Dhabi Emirate, 2005 and 2012.
Source: SCAD, Statistical Year Books 2011 and 2013, accessed April 2014 at http://www.scad.ae/en/statistics/Pages/Statistics.aspx?ThemeID=4
&TopicID=14&SubTopicID=56

study identified that age-adjusted diabetes prevalence ranged
from 15.9% for people from Jordan, Palestine, Syria, Lebanon
and Iraq; to 20.9% for people from South Asia, compared with
25.1% for UAE citizens. Clearly, the exclusion of a large number
of expatriates would result in higher National prevalence rates.

There is no real basis for an assertion that diabetes prevalence
is increasing in the UAE population. To assess trends in diabetes
prevalence, regular well-structured population surveys using
appropriate diagnostic tools are required, particularly to assess
whether prevalence is increasing for each age/sex group. This
has not occurred in UAE, so there is no valid way to judge whether
age/sex-specific rates underlying national prevalence rates are
changing over time.

The Weqaya programme, which achieved around 95% health
surveillance penetration of the Abu Dhabi citizen population
from 2008-2012, may provide useful confirmation of diabetes
prevalence rates among the citizen population. However the
data and data collection methodology is not publicly available.
Weqaya data is not referenced by IDF.

Undiagnosed diabetes is starting to trend down in the USA
[38] and Kuwait [39], possibly demonstrating the effectiveness
of health promotion and public awareness programs [40], such
as are made in the UAE. Forward projections including high
estimates for undiagnosed diabetes may be suspect in UAE and
other counties where the public and clinical profile of diabetes
is high [41].

Citation: Hunter LH, Robb WF, Brownie SM (2014) The “Secret” Impact of Population Statistics on the Metrics of Diabetes. J Diabetes Metab Disord
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Diabetes incidence
There is no publicly available data on diabetes incidence
at the UAE level. We do not know how many new cases are
diagnosed each year, or the number of people living with a
diagnosis of diabetes. We are unable to calculate age/sex- or age/
sex/citizenship-specific rates.

Diabetes-related mortality rates

Despite the comparatively high prevalence of diabetes in
the UAE [1], diabetes still does not show up prominently in UAE
death records. In 2010, around 4.14% of all deaths (both citizens
& non-citizens) were attributed to diabetes. However, for 10.8%
of all deaths the cause was “not stated”. This may indicate that
diabetes related mortality is understated [42]. About 80% of the
recorded diabetes deaths were in the age range 20 to 79 years,
[42] the age range of interest to the IDF.
In the absence of available official UAE population estimates
by age group, gender and citizenship, diabetes-related mortality
rates can only be calculated using the UN population estimates
for 2010. These indicate the rates rise from 0.2 per 1,000 for age
group 55-59 years to 2.3 per 1,000 for 65-69 then increasing to
7.11 per 1000 for age group 70-74 years up to 11.1 for those 80+
(Figure 9) [11].

This means that population estimates for the older age groups
are the most critical in the calculation of diabetes metrics.

Impact

The implications of inaccurate population-based metrics are
wide reaching.

Impact of population data on diabetes metrics

Changes in diabetes metrics can occur on the basis of
differences in the following population-based statistics:
•
•
•

The total population.

The population structure by age and sex, and by
nationality/ethnicity.
Age/sex-specific prevalence rates.
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If the total population estimate for people aged 20 - 79 years
is higher than actual, then:
•
•
•

Estimates of the number of people with diabetes will be
overstated.
Incidence rates will be understated.

Diabetes-related mortality rates will be understated.

If the population estimates overstate the percentage of the
population in older age groups:
•
•
•

Estimates of the number of people with diabetes will be
overstated.
Crude prevalence rates will be overstated.

Age-specific mortality rates will be understated.

If the population estimates understate the percentage of the
UAE population who are expatriates:
•
•

Estimates of the number of people with diabetes will be
overstated.
Crude prevalence rates will be overstated.

Given the impact of population data on diabetes metrics, it
is important that collection of statistics includes all relevant
population characteristics and can be related to the relevant
subpopulations. A true picture of the UAE population would
recognize the presence and demographic characteristics of its
sub-populations.

Impact on health service planning and delivery

The UAE invests heavily in health infrastructure and best
practice health service delivery. If diabetes prevalence rates are
to be used to guide public policy, resource and infrastructure
planning, then valid data is critical, including population and
population-based data. The prevention and management of
diabetes and related non-communicable diseases (NCD) within
the UAE is based on population data, which may be the best
available, but is not recognized to be of sufficient reliability
within the UAE.

UAE has become a hub for medical infrastructure and career

Figure 9: Age/sex-specific mortality rates for diabetes UAE, 2010 [11].
Data Sources: Ministry of Health, UAE, Distribution Of Deaths By Cause, Sex, Nationality And Age Group, 2010 http://www.moh.gov.ae/en/
OpenData/Pages/OpenData.aspx?Category=Statistics Search keywords “deaths by cause”
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investment, and for medical tourism. Outdated IDF rankings are
sometimes cited [7,43] alongside newer IDF data to make a point.
The IDF Atlas [1] provides an annual view of diabetes globally,
regionally and at country level. They caution against longitudinal
use of their data and metrics. IDF data cannot be used to
demonstrate an increase or decrease in comparative prevalence
because of profound changes in methodology in 2011, which
are implemented in the 5th Edition of the Atlas. [12,44] Crude
prevalence of diabetes in the UAE (the prevalence within UAE,
using UAE population count) cannot be used for comparative
purposes within the UAE as these rates are based on just one
study; or externally because of differences in the population
structure and dynamics of other countries.
In the absence of publically available unambiguous data,
people will draw wrong conclusions and health planning will be
flawed.

Impact on clinical research

Clinical studies also should be representative of the
population. Insufficient sample size and sampling bias can
undermine the usefulness of results. Inappropriate selection of
study participants and controls can mislead results. For instance,
in 2006, WHO [45] addressed inconsistent diagnostic criteria
which had limited the usefulness of much diabetes research.
Chiefari et al. [46] who investigated the association of Diabetes
mellitus Type 2 with genetic variants discussed the significant
difficulty in defining the appropriate control group to exclude
individuals with insulin resistance. As diabetes is an agerelated disease, given that its prevalence increases with the age,
choosing young subjects as controls could involve the erroneous
enrollment of individuals not yet diabetic.

Clinical implications

Clinicians would be aware of the population characteristics
(e.g. aging) most associated with diabetes, but may not be
aware of the actual extent of the disease and the real trends.
While clinical impression may confirm high prevalence for
diabetes, there is insufficient available evidence to suggest that
the prevalence of diabetes in either the citizen or non-citizen
population is increasing. Clinical impression may also suggest
that diabetes is diagnosed at younger age groups than elsewhere,
but without population and diabetes data available in standard
5-year age groupings, there is also insufficient evidence to
support this comparison.
Without accurate, timely information UAE clinicians may
be led to practices that do not reflect the actual likelihood of
patients having diabetes. The fact that Malik et al. [4] estimates
that over 40% of all people aged 55+ years in UAE had diabetes,
that over 40% of all people with diabetes were undiagnosed,
and that citizens are much more likely to have diabetes should
impact on diagnostic alertness and practice in UAE. The extent
to which these statistics are out of date should also be of concern
to clinicians.
All clinicians are urged to take note that the quality of health
statistics depends not only on how well and often governments
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undertake population census, carry out health surveillance and
manage health data collections; but how well doctors fill out
the ‘dreaded paperwork’! For instance, doctors can attend to
underreporting and sparse cause-of-death data. WHO guidelines
are available for death certification [47]. Practical guidelines [48]
recommend that diabetes can be recorded as the “immediate
cause of death” or the “underlying cause of death” but that more
often than not these causes are not in the sequence of events
leading to death. Diabetes is more often a “contributory cause
of death”, and should be recorded in this manner. In perinatal
deaths, diabetes may be recorded as a “maternal disease affecting
the infant”.

Conclusion

Valid data sets are essential to health service planning,
effective disease prevention strategies and early diagnosis and
treatment. This study has identified a number of issues with
population data and diabetes metrics in the UAE.
•
•
•
•

•
•

Publicly available estimates of total population of the UAE
have varied by as much as 79%.

The latest available official population estimates relate to
2010 and these are based on 2005 census data.

There is no publicly available data on the structure of the
population in the UAE since 2005.
Given that the UAE population is substantially composed
of male non-citizens who are replaced, the ageing of
the population is limited to the citizens’ portion of the
population.
There are no projections of the population of the UAE that
adequately address the expatriate population.

Only one prevalence study of sufficient quality has been
done for UAE. This was in 1999-2000, is now out of date,
and excluded the large population of people resident in
workers camps.

While these issues are by no means unique to the UAE, to plan
future services for diabetes, the above gaps in population data
need to be addressed, particularly time series of prevalence rates.
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